| Serial Number | 79258665 |
| Word Mark | GENOSCIENCE PHARMA |
| Filing Date | Friday, February 1, 2019 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, August 25, 2020 |
| Registration Number | 6132420 |
| Registration Date | Tuesday, August 25, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 9, 2020 |
| Disclaimer with Predetermined Text | "PHARMA" |
| Goods and Services | Active chemical ingredients used in the manufacture of anti-cancer drugs; chemical products intended for pharmaceutical sciences, namely, chemical additives for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry, namely, preservatives for use in the pharmaceutical industry; antioxidants for the manufacture of pharmaceutical products; chemical preparations for be used in the manufacture of pharmaceutical products, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer-related diseases or conditions; chemicals for use in biotechnological product development; enzymes derived from biotechnological processes for industrial use; chemicals used in biotechnological manufacturing processes; diagnostic preparations and diagnostic reagents for scientific or research use; reagents and solvents for sample preparation, modification and manipulation of cells, as well as for the implementation of marking methods, separation, isolation, reproduction and/or cleaning of biopolymers, nucleic acids, proteins, macromolecules, namely, reagents for scientific use and biologically active substances for diagnostic use, namely, biologically active enzymes and microorganisms that are aimed as sanitizing water environments and to treat the activation and optimization of biological filter systems |
| Goods and Services | Pharmaceutical preparations, pharmaceutical products, and pharmaceutical substances, namely, pharmaceutical preparations for the treatment of cancer-related diseases or conditions; pharmaceutical preparations for cancer treatment; biopharmaceutical products for cancer treatment, namely, biological preparations for the treatments of cancer; pharmaceutical products for cancer treatment; pharmaceutical preparations and substances for cancer prevention; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for cancer prevention and treatment; biotechnological preparations for medical use, namely, biological tissue cultures for medical purposes; diagnostic agents for medical use; strips for medical diagnosis, namely, medical diagnostic test strips for cancer diagnosis; diagnostic preparations for medical use; diagnostic reagents for medical use; diagnostic substances for medical use; pharmaceutical medicine products and diagnostic products for sample preparation, modification and manipulation of cells and for marking, separation, isolation, reproduction and/or cleaning of biopolymers, nucleic acids, proteins, macromolecules and biologically active substances, namely, chemical reagents for medical purposes |
| Goods and Services | Development of new technology on behalf of third parties in the field of genetics and biotechnology; biotechnological processes for regulating, modifying and characterizing of disease conditions, medical research specialized in the biotechnological field with respect to regulating, modifying and characterizing diseases or conditions; research and development for third parties in the field of biotechnology; manufacturing and consolidating upon request of DNA, biological organisms, cells, viruses, pathogens, special cells which have been genetically modified according to the specification of third parties for scientific, medical and laboratory use and for research, namely, medical and scientific laboratory services; gene therapy services for third parties, namely, scientific research and product development regarding DNA, biological organisms, cells, viruses, pathogens and special cells which have been genetically modified for scientific and medical use and for research; scientific and technological services, namely, research and design in the field of medical treatment, namely, cancer treatment; industrial analysis and research services, namely, testing, analysis and evaluation of drugs for treatment of cancer and cancer-related diseases and conditions to assure compliance with industry and regulatory standards; research and development of anti-cancer drugs; development of pharmaceutical preparations and medicines; development of pharmaceutical products; development of chemical compounds, namely, custom design and development of reagents and biochemical assays; research and development of new products for others with respect to chemical compounds for therapeutic use; pharmaceutical drug development services for anti-cancer drugs; evaluation of pharmaceutical products; research in the field of pharmaceutical products, namely, pharmaceutical research and development; pharmaceutical research and development in the field of anti-cancer drugs; pharmaceutical research and development services; pharmaceutical research; carrying out clinical trials for pharmaceutical products, namely, conducting clinical trials for others; conducting cancer treatment clinical trials for others; provision of medical and scientific research information concerning the results of clinical trials for pharmaceutical products; laboratory research services in the field of pharmaceuticals; laboratory research services for cancer treatment; testing, inspection and research services in the field of pharmaceuticals; testing, inspection and research for pharmaceuticals for cancer treatment; biotechnological research services; preparation of reports in the field of biotechnology; research and development in the field of biotechnology; services provided by consultants in the field of biotechnology, namely, scientific research consulting in the field of biotechnology; providing scientific research information in the biochemical and biotechnological fields; product design and development in the field of medical and pharmaceutical diagnostic apparatus |
| Goods and Services | Medical analysis services for diagnosing cancer; medical analysis of RNA or DNA for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; colorectal cancer screening services; medical services for diagnosing diseases; medical diagnosis of cancer-related diseases or conditions; medical testing for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis; medical testing and analysis for diagnostic or treatment purposes |
| Pseudo Mark | GENO SCIENCE PHARMACEUTICAL |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 20, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 20, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 20, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, May 20, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GENOSCIENCE PHARMA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Party Name | GENOSCIENCE PHARMA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Party Name | GENOSCIENCE PHARMA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 34 - NOT AVAILABLE |
| Address | FR |
| Event Date | Event Description |
| Sunday, January 3, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, December 16, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, December 15, 2020 | FINAL DISPOSITION PROCESSED |
| Wednesday, November 25, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, August 25, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 9, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 9, 2020 | PUBLISHED FOR OPPOSITION |
| Friday, June 5, 2020 | NOTIFICATION PROCESSED BY IB |
| Wednesday, May 20, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, May 20, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, May 20, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, May 4, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, April 30, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 30, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 30, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, January 13, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, January 13, 2020 | FINAL REFUSAL E-MAILED |
| Monday, January 13, 2020 | FINAL REFUSAL WRITTEN |
| Wednesday, December 18, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 18, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 18, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 12, 2019 | REFUSAL PROCESSED BY IB |
| Monday, June 24, 2019 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, June 24, 2019 | REFUSAL PROCESSED BY MPU |
| Tuesday, June 4, 2019 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, June 3, 2019 | NON-FINAL ACTION WRITTEN |
| Friday, May 24, 2019 | APPLICATION FILING RECEIPT MAILED |
| Monday, May 20, 2019 | ASSIGNED TO EXAMINER |
| Monday, May 20, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, May 16, 2019 | SN ASSIGNED FOR SECT 66A APPL FROM IB |